Leukemia symptoms are rarely dramatic at the start, and that is what makes them hard to interpret. Tiredness that does not lift, bruises that appear without a knock, infections that keep coming back, sweating at night — each has far more common explanations. Leukemia is a cancer of the blood-forming cells inside the bone marrow, and it accounts for only a small share of cancer diagnoses in the United States. Most people who worry about it turn out to have something else entirely.
In this article you’ll learn what leukemia is, how the four main types differ, which signs justify a medical opinion, why a blood test raises the question while a bone marrow examination answers it, and what treatment looks like today.
What leukemia is, in plain terms
Leukemia is a cancer that starts in the cells your bone marrow uses to build blood. The marrow is the soft tissue inside your larger bones, and it produces red blood cells that carry oxygen, platelets that stop bleeding, and white blood cells that fight infection.
In leukemia, one of those developing cell lines acquires a genetic change and multiplies without stopping. The abnormal cells crowd the marrow and spill into the bloodstream without doing the job a finished blood cell does. As they take up space, the marrow makes fewer normal cells, and that shortage explains most of what a person feels: low red cells cause fatigue and breathlessness, low platelets cause bruising and bleeding, and too few working white cells cause repeated infections.
How blood cells normally form
All blood cells descend from one family of stem cells in the marrow, and early on that family splits into two branches. The myeloid branch produces red cells, platelets, and most infection-fighting white cells such as neutrophils. The lymphoid branch produces lymphocytes, the cells of immune memory. Which branch goes wrong is one of the two questions that names the disease. Every lab report showing all three families includes a complete blood count panel.
Leukemia symptoms and what they usually mean
No symptom belongs to leukemia alone. Doctors look at the combination, the duration, and whether anything shows up on a blood test. Chronic forms often produce nothing at all and are found by accident during a routine check.
The most frequently reported signs
- Persistent fatigue and weakness that rest does not fix
- Fever or chills without a clear infection
- Infections that are frequent, severe, or slow to clear
- Easy bruising, bleeding gums, or prolonged nosebleeds
- Petechiae, small flat red or purple dots on the skin
- Drenching night sweats
- Unintentional weight loss
- Bone or joint tenderness, especially in children
- Swollen lymph nodes, or fullness under the left ribs from an enlarged spleen
The Mayo Clinic lists this same cluster and adds a caution worth repeating: most people with known risk factors never develop leukemia, and many who do have none at all.
Why these symptoms are usually something else
This is the part most articles skip. Fatigue is one of the most common reasons people see a doctor, and the overwhelming majority of cases trace back to sleep debt, low iron, thyroid problems, depression, or viral infections. Bruising increases with age, with aspirin and anticoagulants, and with a mild dip in platelets after a virus. Swollen nodes accompany almost every throat infection, and night sweats are common around menopause.
The same logic applies to a blood test. An abnormal white cell count is one of the most frequent findings in general practice, and infection, inflammation, smoking, physical stress, pregnancy, corticosteroids, and allergy account for the vast majority. People whose report shows a raised value should also review a neutrophil count. The pattern across cell types tells a doctor far more than any single number.
What makes a doctor look further
A hematologist becomes concerned when several things line up: a white cell count that is very high or very low rather than mildly off, a drop in two or three cell lines together, immature cells on the slide, symptoms lasting weeks, or a result that worsens on a second test. One isolated number outside the reference range, in someone who feels well, is a weak signal.
The four main types of leukemia
Leukemia is named by answering two questions: is it fast or slow, and which branch of blood cell production is involved? Those answers give the four classic types, which behave so differently that treating them as one disease is misleading.
Acute versus chronic
Acute leukemia comes from very immature cells, called blasts, that multiply quickly; symptoms appear over days to weeks and treatment starts promptly. Chronic leukemia comes from more mature cells that accumulate slowly, can sit quietly for years, and is sometimes monitored rather than treated.
Myeloid versus lymphoid
Myeloid leukemia arises from the branch that makes red cells, platelets, and neutrophils; lymphoid leukemia from the branch that makes lymphocytes. Anyone making sense of that on their own report should first check the lymphocyte count.
| Type | Cells involved | Pace | Most often affects | Usual first clue |
|---|---|---|---|---|
| ALL, acute lymphoblastic leukemia | Immature lymphocytes | Fast | Children and young adults; a smaller peak after 60 | Bruising, bone pain, fatigue over weeks |
| AML, acute myeloid leukemia | Immature myeloid cells | Fast | Adults, rising sharply after 65 | Sudden fatigue, infection, or bleeding |
| CLL, chronic lymphocytic leukemia | Mature-looking B lymphocytes | Slow | Older adults; the most common leukemia | A high lymphocyte count on a routine test in someone who feels fine |
| CML, chronic myeloid leukemia | Mature-looking myeloid cells | Slow | Middle-aged and older adults | A high white cell count with an enlarged spleen |
Two related blood cancers are often confused with leukemia. Cancers beginning in lymph nodes rather than marrow define lymphoma, while cancers of antibody-producing plasma cells in the marrow define multiple myeloma. The distinction matters because tests and treatments diverge early.
Causes and risk factors
Leukemia begins with a genetic change acquired by a blood-forming cell during a person’s life, and in most cases nobody can say why. It is not contagious, not caused by stress, and not caused by anything a parent did or failed to do.
Factors linked to a higher risk
- Previous chemotherapy or radiation therapy for another cancer
- Long-term occupational exposure to benzene
- Cigarette smoking, linked in particular to acute myeloid leukemia
- Certain inherited conditions, including Down syndrome
- A first-degree relative with chronic lymphocytic leukemia
- Increasing age, the strongest factor for AML, CLL, and CML
These are associations, not switches. Risk factors shift the odds slightly across whole populations and say very little about any one person, and most people with a listed risk factor never develop leukemia. Cell phones, microwave ovens, hair dye, sugar, and household wiring have all been investigated and none causes leukemia. It is not transmitted by transfusion or by contact.
How leukemia is diagnosed
The most useful thing to understand about diagnosis is the division of labor between tests. Blood tests raise the question. Bone marrow examination answers it. Nobody is diagnosed with leukemia on a blood count alone.
Step one: the complete blood count
A complete blood count measures red cells, white cells, and platelets. In leukemia it is usually abnormal, but not specifically so. What draws attention is a pattern: a very high or very low white cell count combined with a fall in red cells and platelets. Someone whose report shows a low red cell value should also check a hemoglobin measurement. Iron deficiency, chronic disease, and blood loss explain the many common causes of anemia. A falling platelet value means more when an earlier test also recorded a platelet count, since the trend outweighs one reading.
Step two: the peripheral blood smear
A drop of blood is spread on a glass slide and examined under a microscope. Here a trained eye sees what an automated counter cannot: blast cells that should never leave the marrow, or lymphocytes with a distinctive appearance. The smear is fast, cheap, and often the moment the question is first raised. Hematologists also use the slide to confirm a persistently raised monocyte count.
Step three: bone marrow aspiration and biopsy
Under local anesthetic, a needle takes a small sample of liquid marrow and a tiny core of bone, usually from the back of the hip. It takes about twenty minutes, and most people describe brief pressure rather than lasting pain. The sample shows what proportion of the marrow is made of abnormal cells, and that is the finding that confirms or excludes the diagnosis.
Step four: immunophenotyping and genetic testing
Flow cytometry passes cells one by one through a laser and reads the protein markers on their surface, identifying which branch they came from and how mature they are. Chromosome analysis and gene sequencing then look for specific alterations, such as the Philadelphia chromosome that defines chronic myeloid leukemia. These results decide the subtype, the expected course, and which drugs will work — which is why the answer takes days rather than minutes.
Supporting tests
Doctors often add kidney and liver panels, clotting studies, and an LDH blood test. Its value rises when many cells are broken down, which happens in fast-growing leukemias but also in dozens of harmless situations.
When to see a doctor
Proportion matters: neither ignore symptoms nor treat every bruise as an emergency.
Seek care the same day
- Bleeding that will not stop, from gums, nose, or a cut
- A fever above 100.4°F during cancer treatment or with a known low white cell count
- Sudden severe breathlessness, confusion, or a rash of dark spots spreading quickly
Book an appointment within a week or two
- Fatigue that has lasted more than a month and is getting worse
- Unexplained bruising in unusual places such as the trunk or back
- Repeated infections over several months in someone not normally prone to them
- Unintentional weight loss of more than five percent of body weight
- Drenching night sweats lasting several weeks
- A painless firm lymph node that has grown over more than two weeks
Mention it at your next routine visit
- A single mildly abnormal blood count in someone who feels well
- Occasional tiredness that improves with rest
- A bruise you can explain
A repeat test in six weeks rather than an urgent referral is a judgment based on the whole picture, not a delay.
How leukemia is treated today
Treatment depends almost entirely on the subtype, and the differences are large.
Acute leukemias
Treatment usually begins within days. Induction chemotherapy clears the marrow of leukemia cells and restores normal blood production, followed by consolidation to prevent return. Acute lymphoblastic leukemia has traditionally required two to three years of maintenance therapy. Targeted drugs and antibody-based immunotherapies increasingly replace part of chemotherapy, and a stem cell transplant is reserved for higher-risk cases.
Chronic leukemias
Chronic myeloid leukemia is treated with daily oral tyrosine kinase inhibitors, tablets that block the abnormal protein driving the disease. Chronic lymphocytic leukemia is often not treated at diagnosis; many people are monitored for years, and treatment begins only when the disease becomes symptomatic. Targeted tablets and antibody combinations have then largely replaced older chemotherapy.
Supportive care
Patients also receive transfusions, antibiotics, antifungal prevention, anti-nausea medication, and nutritional support. This part of care accounts for a meaningful share of survival gains over two decades.
Living with leukemia and long-term outlook
Outlook varies more within leukemia than between many separate diseases. Age, subtype, genetic profile, and how completely the marrow clears after the first round of treatment all shape it. Childhood acute lymphoblastic leukemia now has one of the highest cure rates in oncology, and chronic myeloid leukemia, once uniformly fatal, is managed by many people with a daily tablet. A conversation with a hematologist is more useful than any published average, because those figures describe groups treated years ago rather than the individual in the room. Day to day, people in treatment keep up gentle activity, prioritize food safety while immunity is low, follow their team’s vaccine guidance, and report fever promptly. Fatigue often outlasts treatment by months, and that is expected rather than a sign of relapse.
Latest scientific advances
Here is what has actually changed in recent years, in plain language.
Chronic myeloid leukemia has become a manageable long-term condition
A 2025 review in JAMA described how targeted tablets transformed this disease. Before them, a substantial proportion of patients died each year; today, people who take their medication consistently live about as long as people of the same age without the disease. What this means for you: this diagnosis is very different from what older material online describes, and taking the tablet reliably matters more than anything else.
Acute myeloid leukemia now has more than a dozen approved drugs
Two 2025 reviews describe how, after decades with one chemotherapy backbone, around a dozen new agents have been approved since 2017. Most are targeted therapies — drugs aimed at a specific genetic fault in the leukemia cell rather than at dividing cells in general. What this means for you: genetic testing at diagnosis decides which of these drugs is offered, which is why treatment does not always start the same day.
Immunotherapy is reshaping acute lymphoblastic leukemia in adults
A 2025 review in JAMA Oncology reported that combining antibody-based immunotherapies with targeted tablets, in place of some traditional chemotherapy, has lifted four-year survival for several adult subtypes to roughly four patients in five — a level not previously seen in adults. These come from specialist centers and the approach is still being refined. What this means for you: adults with this diagnosis have good reason to ask about a specialist center or a clinical trial.
Measuring the leukemia that a microscope cannot see
Reviews published in 2024 and 2025 examined measurable residual disease — a way of detecting the few leukemia cells left after treatment, far below what a microscope can spot, using flow cytometry or gene sequencing. Patients whose tests come back clear at this deeper level consistently do better. What this means for you: a repeat bone marrow test after treatment is how teams decide whether to stop, continue, or intensify, not a sign that something has gone wrong.
Chronic lymphocytic leukemia treatment is becoming shorter
A 2025 review reported that combinations of targeted tablets now allow fixed-duration treatment: a defined course rather than medication continued indefinitely. Remissions are deep and durable and patients get treatment-free time, though whether this is a cure is unknown. What this means for you: it is reasonable to ask whether a fixed-duration option applies.
Where progress remains slow
A 2025 review highlighted that acute myeloid leukemia carrying a change in the TP53 gene still responds poorly, regardless of age or fitness. None of this changes the basic advice: symptoms are interpreted by a doctor who sees the whole picture, and the diagnosis is confirmed in the marrow. The National Cancer Institute maintains a regularly updated leukemia resource.
Glossary
| Term | Definition |
|---|---|
| Blast | An immature blood cell that normally stays inside the bone marrow. Finding blasts circulating in the blood is one of the strongest reasons to investigate further. |
| Bone marrow aspiration and biopsy | A procedure that removes a small sample of liquid marrow and a tiny core of bone, usually from the hip, under local anesthetic. It is the test that confirms or rules out leukemia. |
| Peripheral blood smear | A drop of blood spread on a glass slide and examined under a microscope, so a specialist can see the shape and maturity of individual cells. |
| Flow cytometry | A laboratory method that passes cells one at a time through a laser to read the protein markers on their surface, identifying exactly which cell type has become abnormal. |
| Measurable residual disease, or MRD | A very small number of leukemia cells left after treatment, too few to see under a microscope but detectable with sensitive laboratory methods. |
| Philadelphia chromosome | A specific swap of material between two chromosomes that creates an abnormal growth signal. It defines chronic myeloid leukemia and appears in some cases of acute lymphoblastic leukemia. |
| Tyrosine kinase inhibitor | A tablet that blocks a specific abnormal protein driving cancer cell growth. These drugs are the standard treatment for chronic myeloid leukemia. |
| Petechiae | Tiny flat red or purple dots on the skin caused by bleeding from very small vessels, often a sign that platelets are low. |
| Stem cell transplant | A treatment that replaces diseased bone marrow with healthy blood-forming stem cells, usually from a donor, after intensive conditioning therapy. |
| Immunotherapy | Treatment that uses the immune system, or laboratory-made antibodies, to find and destroy cancer cells rather than poisoning all dividing cells. |
Frequently asked questions
Can leukemia be cured?
Some forms can. Childhood acute lymphoblastic leukemia has one of the highest cure rates of any cancer, and a growing share of adults with acute leukemias reach long-term remission, particularly with newer targeted and antibody-based treatments. Chronic myeloid leukemia is usually not described as cured, but daily tablets control it so effectively that many people live a normal lifespan. Chronic lymphocytic leukemia is often managed rather than cured, sometimes with long periods requiring no treatment at all. The realistic answer depends on subtype, genetics, and age, so it is a question to put directly to a hematologist who has the full test results.
What are the early symptoms of leukemia in adults?
Early signs tend to be unremarkable: tiredness, mild breathlessness on exertion, more infections than usual, bruises appearing without cause, or a low-grade fever that lingers. Chronic forms frequently produce no symptoms and are found through a routine blood test done for another reason. Because these symptoms overlap with extremely common conditions, the useful question is not whether you have any of them but whether they are persistent, worsening, and accompanied by an abnormal blood count.
Are there skin signs of leukemia?
Skin changes can occur. Petechiae, the pinpoint red dots caused by low platelets, are the most frequently described, along with bruising that appears easily and pale skin from low red cell counts. Rarely, leukemia cells collect in the skin and form firm reddish or purple patches. However, most rashes, dots, and bruises seen day to day have entirely unrelated causes, from minor injury to viral illness to fragile skin with age. Skin changes are worth showing to a doctor, especially if they spread quickly, but they are not a diagnosis on their own.
Does a high white blood cell count mean leukemia?
Almost never. A raised white cell count is one of the most common laboratory findings there is, and infection, inflammation, physical stress, smoking, pregnancy, allergy, and steroid medication explain the overwhelming majority. What concerns a doctor is a count that is extremely high or extremely low, that is accompanied by falling red cells or platelets, that shows immature cells on the slide, or that keeps rising across repeated tests.
Is leukemia hereditary?
In the vast majority of cases it is not inherited. The genetic change happens in a single blood-forming cell during a person’s life and is not passed to children. A small number of inherited conditions raise risk, and chronic lymphocytic leukemia shows a modest tendency to run in families, but even then most relatives never develop it. There is no routine genetic screening recommended for family members of someone with leukemia.
How long does it take to get a diagnosis?
A complete blood count usually returns within a day. If the result and the smear raise the question, a bone marrow test is typically arranged within days, and the initial marrow assessment can be available quickly. The full picture, including flow cytometry and genetic analysis, generally takes several more days to a couple of weeks. That wait is uncomfortable but purposeful, since the exact subtype determines the treatment.
Sources
- National Library of Medicine, MedlinePlus — Leukemia, 2025 — medlineplus.gov
- Mayo Clinic — Leukemia: symptoms and causes, 2024 — mayoclinic.org
- Cleveland Clinic — Leukemia: types, diagnosis and treatment, 2024 — my.clevelandclinic.org
- Shimony S, Stahl M, Stone RM — Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and Management — American Journal of Hematology, 2025 — doi.org/10.1002/ajh.27625
- Kantarjian HM, DiNardo CD, Kadia TM, et al. — Acute myeloid leukemia management and research in 2025 — CA: A Cancer Journal for Clinicians, 2024 — doi.org/10.3322/caac.21873
- Jabbour E, Kantarjian H — Chronic Myeloid Leukemia: A Review — JAMA, 2025 — doi.org/10.1001/jama.2025.0220
- Kantarjian H, Aldoss I, Jabbour E — Management of Adult Acute Lymphoblastic Leukemia: A Review — JAMA Oncology, 2025 — doi.org/10.1001/jamaoncol.2025.0613
- Hallek M — Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy — American Journal of Hematology, 2025 — doi.org/10.1002/ajh.27546
- Ally F, Chen X — Acute Myeloid Leukemia: Diagnosis and Evaluation by Flow Cytometry — Cancers, 2024 — doi.org/10.3390/cancers16223855
- Sallman DA, Stahl M — TP53-mutated acute myeloid leukemia: how can we improve outcomes? — Blood, 2025 — doi.org/10.1182/blood.2024024245
- Pölönen P, Mullighan CG, Teachey DT — Classification and risk stratification in T-lineage acute lymphoblastic leukemia — Blood, 2025 — doi.org/10.1182/blood.2023022920
Further reading
- Readers comparing allergy-related white cell patterns often review eosinophil blood levels
- Many readers also check basophil blood test results
- Anyone tracking platelet trends should also read mean platelet volume results
- Laboratories routinely report platelet distribution width results
- Urine testing has its own immune marker: some readers also review white blood cell levels in urine
Understand your lab results with BloodSense
Most people first meet these questions while holding a lab report they cannot read. BloodSense reads that report with you, in plain language, explaining what a white cell count, a hemoglobin value, a platelet count, or a lactate dehydrogenase result means in the context of the rest of your panel. It helps you understand your results and prepare better questions for your appointment. It does not diagnose leukemia or any other condition, and it does not replace your doctor.
